Signed the contract between Prolabin & Tefarm and the University of Perugia, Department of Medicine for co-funding a PhD in “biotechnology of immune and infectious disease systems” (XXXVII CYCLE, 2021-2024) titled “Innovative mRNA therapeutics development for inflammatory and autoimmune disorders”.